29 related articles for article (PubMed ID: 38699697)
1. Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients.
Geng J; Jinli S; Guo W; Li H; Dan Y; Gao Y
J Med Biochem; 2024 Apr; 43(2):234-242. PubMed ID: 38699697
[TBL] [Abstract][Full Text] [Related]
2. Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
Zhao S; Mei Y; Wang J; Zhang K; Ma R
PLoS One; 2016; 11(6):e0157639. PubMed ID: 27327081
[TBL] [Abstract][Full Text] [Related]
3. Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.
Zhao S; Mei Y; Wang Y; Zhu J; Zheng G; Ma R
Int J Clin Exp Med; 2015; 8(11):20837-44. PubMed ID: 26885008
[TBL] [Abstract][Full Text] [Related]
4. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
[TBL] [Abstract][Full Text] [Related]
5. Strategies for five tumour markers in the screening and diagnosis of female breast cancer.
Luo J; Xiao J; Yang Y; Chen G; Hu D; Zeng J
Front Oncol; 2022; 12():1055855. PubMed ID: 36755860
[TBL] [Abstract][Full Text] [Related]
6. Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations.
Li G; Zhang H; Zhang L; Liu H; Li S; Wang Y; Deng X
Biomed Res Int; 2022; 2022():1394042. PubMed ID: 36299704
[TBL] [Abstract][Full Text] [Related]
7. Serum fetuin-A and RANKL levels in patients with early stage breast cancer.
Afsar CU; Aral H; Can O; Can TD; Karacetin D; Ali NM; Umar GR; Karabulut S
J Med Biochem; 2023 Mar; 42(2):249-257. PubMed ID: 36987423
[TBL] [Abstract][Full Text] [Related]
8. Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.
Jia L; Li G; Ma N; Zhang A; Zhou Y; Ren L; Dong D
BMC Cancer; 2022 Jul; 22(1):760. PubMed ID: 35831854
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.
Einama T; Yamagishi Y; Takihata Y; Suzuki T; Yamasaki T; Hirose Y; Kobayashi K; Yonamine N; Fujinuma I; Tsunenari T; Koga M; Ishibashi Y; Nagata K; Shiraishi T; Nakazawa A; Iwasaki T; Shinto E; Kato K; Sato K; Ueno H; Kishi Y; Tsuda H
Biomark Res; 2021 Oct; 9(1):78. PubMed ID: 34715925
[TBL] [Abstract][Full Text] [Related]
10. Nipple Discharge: Current Clinical and Imaging Evaluation.
Gupta D; Mendelson EB; Karst I
AJR Am J Roentgenol; 2021 Feb; 216(2):330-339. PubMed ID: 33295815
[No Abstract] [Full Text] [Related]
11. The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum.
Patuleia SIS; van Gils CH; Oneto Cao AM; Bakker MF; van Diest PJ; van der Wall E; Moelans CB
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187146
[TBL] [Abstract][Full Text] [Related]
12. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.
Choi JH; Ro JY
Adv Anat Pathol; 2021 Jan; 28(1):44-58. PubMed ID: 32960834
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-based biosensor for detecting carcinoembryonic antigen.
Xiang W; Lv Q; Shi H; Xie B; Gao L
Talanta; 2020 Jul; 214():120716. PubMed ID: 32278406
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
